Stimulating Fat Breakdown AOD-9604 activates processes that break down fat cells, helping to reduce body fat
N Engl J Med 2025;393:1796-1806 [9] Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial, December 2025: Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial | Eli Lilly and Company [10] Fourth High-level Meeting of the UN General Assembly on the prevention and control of NCDs and the promotion of mental health and wellbeing (HLM4), September 2025: [11] Thousands of patients from Scotlands poorest areas to benefit from landmark UK government-funded obesity study, November 2025: Thousands of patients from Scotlands poorest areas to benefit from landmark UK government-funded obesity study - GOV.UK [12] Non-Traditional Channels: The Compounded GLP-1 Market
BRAWTA CANNOT BE HELD LIABLE FOR ANY SERVICE BEING PROMOTED ON OUT PLATFORM AS WE ADVERTISE, PROMOTE AND MARKET GOODS AND SERVICES ON OUR PLATFORMON BEHALF OF THIRD PARTY VENDORS
Propionyl-L-carnitine May benefit cardiovascular health by improving blood flow
This includes the critical requirement that compounding be pursuant to a valid prescription for an individually identified patient
Recommended dose: 15 to 30 mg daily, taken with food
